Targeted two-photon photodynamic therapy triads

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201000102C
Awardee
Awarding agency
Obligated
$199,386

Award facts

Contract value 100% obligated
$199,386.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 41 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Bozeman, MT 59718, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 3 $0
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award $199,386

About this award

This is a $199,386 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian agency, to Sensopath Technologies, Inc., a woman-owned small business. The contract is for "TAS::75 0849::TAS TARGETED TWO-PHOTON PHOTODYNAMIC THERAPY TRIADS" and has a period of performance through July 8, 2011. The contract was set aside for small businesses.

Quick answers

Who was awarded contract HHSN261201000102C?

HHSN261201000102C was awarded to Sensopath Technologies, Inc. by National Cancer Institute (National Institutes of Health) on September 30, 2010.

How much is contract HHSN261201000102C worth?

The government has obligated $199,386 on HHSN261201000102C.

Was contract HHSN261201000102C competed?

The extent of competition for HHSN261201000102C was full and open competition after exclusion of sources. The government received 41 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award